These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

599 related articles for article (PubMed ID: 10640162)

  • 1. Medical treatment of a grossly enlarged adenomyotic uterus with the levonorgestrel-releasing intrauterine system.
    Fong YF; Singh K
    Contraception; 1999 Sep; 60(3):173-5. PubMed ID: 10640162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of the levonorgestrel-releasing intrauterine system on uterine myomas in a renal transplant patient.
    Fong YF; Singh K
    Contraception; 1999 Jul; 60(1):51-3. PubMed ID: 10549453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progestin receptor isoforms and prostaglandin dehydrogenase in the endometrium of women using a levonorgestrel-releasing intrauterine system.
    Critchley HO; Wang H; Kelly RW; Gebbie AE; Glasier AF
    Hum Reprod; 1998 May; 13(5):1210-7. PubMed ID: 9647549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of ovarian cyst formation in women using the levonorgestrel-releasing intrauterine system vs. hysterectomy.
    Inki P; Hurskainen R; Palo P; Ekholm E; Grenman S; Kivelä A; Kujansuu E; Teperi J; Yliskoski M; Paavonen J
    Ultrasound Obstet Gynecol; 2002 Oct; 20(4):381-5. PubMed ID: 12383322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of levonorgestrel-releasing intrauterine system and T380A intrauterine copper device on dysmenorrhea and days of bleeding in women with and without adenomyosis.
    Kelekci S; Kelekci KH; Yilmaz B
    Contraception; 2012 Nov; 86(5):458-63. PubMed ID: 22832203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A risk-benefit assessment of the levonorgestrel-releasing intrauterine system.
    Sturridge F; Guillebaud J
    Drug Saf; 1996 Dec; 15(6):430-40. PubMed ID: 8968696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of adenomyosis-associated menorrhagia with a levonorgestrel-releasing intrauterine device.
    Fedele L; Bianchi S; Raffaelli R; Portuese A; Dorta M
    Fertil Steril; 1997 Sep; 68(3):426-9. PubMed ID: 9314908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of menorrhagia with a novel 'frameless' intrauterine levonorgestrel-releasing drug delivery system: a pilot study.
    Wildemeersch D; Schacht E
    Eur J Contracept Reprod Health Care; 2001 Jun; 6(2):93-101. PubMed ID: 11518454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hormonal intrauterine devices.
    Rybo G; Andersson K; Odlind V
    Ann Med; 1993 Apr; 25(2):143-7. PubMed ID: 8489751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Morphological and functional features of endometrial decidualization following long-term intrauterine levonorgestrel delivery.
    Critchley HO; Wang H; Jones RL; Kelly RW; Drudy TA; Gebbie AE; Buckley CH; McNeilly AS; Glasier AF
    Hum Reprod; 1998 May; 13(5):1218-24. PubMed ID: 9647550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Levonorgestrel-Releasing Intrauterine System Improves Menorrhagia-Related Quality of Life in Patients with Symptomatic Adenomyosis.
    Ishizawa C; Hirota Y; Iida R; Kaku T; Hirata T; Fukui Y; Omura E; Akaeda S; Hiraoka T; Matsuo M; Osuga Y
    Reprod Sci; 2023 Mar; 30(3):966-973. PubMed ID: 36071343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The treatment with Levonorgestrel Releasing Intrauterine System (LNG-IUS) in patients affected by menometrorrhagia, dysmenorrhea and adenomimyois: clinical and ultrasonographic reports.
    Costanzi F; De Marco MP; Colombrino C; Ciancia M; Torcia F; Ruscito I; Bellati F; Frega A; Cozza G; Caserta D
    Eur Rev Med Pharmacol Sci; 2021 May; 25(9):3432-3439. PubMed ID: 34002816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The LNG-IUS study on adenomyosis: a 3-year follow-up study on the efficacy and side effects of the use of levonorgestrel intrauterine system for the treatment of dysmenorrhea associated with adenomyosis.
    Sheng J; Zhang WY; Zhang JP; Lu D
    Contraception; 2009 Mar; 79(3):189-93. PubMed ID: 19185671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of the levonorgestrel-releasing intrauterine system in the treatment of adenomyosis diagnosed and monitored by magnetic resonance imaging.
    Bragheto AM; Caserta N; Bahamondes L; Petta CA
    Contraception; 2007 Sep; 76(3):195-9. PubMed ID: 17707716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Levonorgestrel-releasing intrauterine system versus a low-dose combined oral contraceptive for treatment of adenomyotic uteri: a randomized clinical trial.
    Shaaban OM; Ali MK; Sabra AM; Abd El Aal DE
    Contraception; 2015 Oct; 92(4):301-7. PubMed ID: 26071673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The levonorgestrel intrauterine system in the management of menorrhagia.
    Barrington JW; Bowen-Simpkins P
    Br J Obstet Gynaecol; 1997 May; 104(5):614-6. PubMed ID: 9166207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-contraceptive uses of levonorgestrel-releasing hormone system (LNG-IUS)--a systematic enquiry and overview.
    Varma R; Sinha D; Gupta JK
    Eur J Obstet Gynecol Reprod Biol; 2006 Mar; 125(1):9-28. PubMed ID: 16325993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of levonorgestrel-releasing intrauterine system on pain and recurrence associated with endometriosis and adenomyosis].
    Deng S; Lang JH; Leng JH; Liu ZF; Sun DW; Zhu L
    Zhonghua Fu Chan Ke Za Zhi; 2006 Oct; 41(10):664-8. PubMed ID: 17199919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A prospective study on the effects of levonorgestrel-releasing intrauterine system for adenomyosis with menorrhagia].
    Li L; Leng JH; Shi JH; Zhang JJ; Jia SZ; Li XY; Dai Y; Zhang JR; Li T; Xu XX; Liu ZZ; You SS; Chang XY; Lang JH
    Zhonghua Fu Chan Ke Za Zhi; 2016 Jun; 51(6):424-30. PubMed ID: 27356477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical experiences of the levonorgestrel-releasing intrauterine system in patients with large symptomatic adenomyosis.
    Park DS; Kim ML; Song T; Yun BS; Kim MK; Jun HS; Seong SJ
    Taiwan J Obstet Gynecol; 2015 Aug; 54(4):412-5. PubMed ID: 26384061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.